Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
   Quality of life scores predict outcome in metastatic but not in early breast cancer
   BREAST
   
   A.S. Coates et al., "Quality of life scores predict outcome in metastatic but not in early breast cancer", BREAST, 10, 2001, pp. 164-170
2. Bernhard, J; Lowy, A; Maibach, R; Hurny, C
   Response shift in the perception of health for utility evaluation: an explorative investigation
   EUROPEAN JOURNAL OF CANCER
   
   J. Bernhard et al., "Response shift in the perception of health for utility evaluation: an explorative investigation", EUR J CANC, 37(14), 2001, pp. 1729-1735
3. Bernhard, J; Sullivan, M; Hurny, C; Coates, AS; Rudenstam, CM
   Clinical relevance of single item quality of life indicators in cancer clinical trials
   BRITISH JOURNAL OF CANCER
   
   J. Bernhard et al., "Clinical relevance of single item quality of life indicators in cancer clinical trials", BR J CANC, 84(9), 2001, pp. 1156-1165
4. Hurny, C
   Communicating about cancer: patients' needs and caregivers' skills
   SUPPORTIVE CARE IN CANCER
   
   C. Hurny, "Communicating about cancer: patients' needs and caregivers' skills", SUPP CARE C, 8(6), 2000, pp. 437-438
5. Morant, R; Bernhard, J; Maibach, R; Borner, M; Fey, MF; Thurlimann, B; Jacky, E; Trinkler, F; Bauer, J; Zulian, G; Hanselmann, S; Hurny, C; Hering, F
   Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma
   ANNALS OF ONCOLOGY
   
   R. Morant et al., "Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma", ANN ONCOL, 11(2), 2000, pp. 183-188
6. Crivellari, D; Bonetti, M; Castiglione-Gertsch, M; Gelber, RD; Rudenstam, CM; Thurlimann, B; Price, KN; Coates, AS; Hurny, C; Bernhard, J; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Goldhirsch, A
   Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
   JOURNAL OF CLINICAL ONCOLOGY
   
   D. Crivellari et al., "Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII", J CL ONCOL, 18(7), 2000, pp. 1412-1422
7. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
   Quality-of-life scores predict outcome in metastatic but not early breast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   A.S. Coates et al., "Quality-of-life scores predict outcome in metastatic but not early breast cancer", J CL ONCOL, 18(22), 2000, pp. 3768-3774
8. von Rohr, E; Pampallona, S; van Wegberg, B; Cerny, T; Hurny, C; Bernhard, J; Helwig, S; Heusser, P
   Attitudes and beliefs towards disease and treatment in patients with advanced cancer using anthroposophical medicine
   ONKOLOGIE
   
   E. von Rohr et al., "Attitudes and beliefs towards disease and treatment in patients with advanced cancer using anthroposophical medicine", ONKOLOGIE, 23(6), 2000, pp. 558-563
9. Sabbioni, MEE; Siegrist, HP; Bacchi, M; Bernhard, J; Castiglione, M; Thurlimann, B; Bonnefoi, H; Perey, L; Herrmann, R; Goldhirsch, A; Hurny, C
   Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment
   BREAST CANCER RESEARCH AND TREATMENT
   
   M.E.E. Sabbioni et al., "Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment", BREAST CANC, 59(3), 2000, pp. 279-287
10. von Rohr, E; Pampallona, S; van Wegbeg, B; Hurny, C; Bernhard, J; Heusser, P; Cerny, T
    Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    
    E. von Rohr et al., "Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer", SCHW MED WO, 130(34), 2000, pp. 1173-1184
11. Bernhard, J; Castiglione-Gertsch, M; Schmitz, SFH; Thurlimann, B; Cavalli, F; Morant, R; Fey, MF; Bonnefoi, H; Goldhirsch, A; Hurny, C
    Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonaltreatment
    EUROPEAN JOURNAL OF CANCER
    
    J. Bernhard et al., "Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonaltreatment", EUR J CANC, 35(6), 1999, pp. 913-920
12. Sabbioni, MEE; Castiglione, M; Hurny, C; Siegrist, HP; Bacchi, M; Bernhard, J; Thurlimann, B; Bonnefoi, H; Perey, L; Goldhirsch, A; Senn, HJ
    Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients
    SUPPORTIVE CARE IN CANCER
    
    M.E.E. Sabbioni et al., "Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients", SUPP CARE C, 7(3), 1999, pp. 149-153
13. Bernhard, J; Hurny, C; Maibach, R; Herrmann, R; Laffer, U
    Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvantchemotherapy
    ANNALS OF ONCOLOGY
    
    J. Bernhard et al., "Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvantchemotherapy", ANN ONCOL, 10(7), 1999, pp. 775-782
14. Bernhard, J; Thurlimann, B; Schmitz, SFH; Castiglione-Gertsch, M; Cavalli, F; Morant, R; Fey, MF; Bonnefoi, H; Goldhirsch, A; Hurny, C
    Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?
    JOURNAL OF CLINICAL ONCOLOGY
    
    J. Bernhard et al., "Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?", J CL ONCOL, 17(6), 1999, pp. 1672-1679
15. HURNY C; BERNHARD J; COATES A
    QUALITY-OF-LIFE MEASUREMENT IN THE IBCSG - PAST, PRESENT AND FUTURE
    European journal of cancer
    
    C. Hurny et al., "QUALITY-OF-LIFE MEASUREMENT IN THE IBCSG - PAST, PRESENT AND FUTURE", European journal of cancer, 34, 1998, pp. 38-38
16. JUNGI WF; BERNHARD J; HURNY C; SCHMITZ SFH; HANSELMANN S; GUSSET H; PESTALOZZI D; GOLDHIRSCH A
    EFFECT OF CARBOPLATIN ON RESPONSE AND PALLIATION IN HORMONE-REFRACTORY PROSTATE-CANCER
    Supportive care in cancer
    
    W.F. Jungi et al., "EFFECT OF CARBOPLATIN ON RESPONSE AND PALLIATION IN HORMONE-REFRACTORY PROSTATE-CANCER", Supportive care in cancer, 6(5), 1998, pp. 462-468
17. VANWEGBERG B; BACCHI M; HEUSSER P; HELWIG S; SCHAAD R; VONROHR E; BERNHARD J; HURNY C; CASTIGLIONE M; CERNY T
    THE COGNITIVE-SPIRITUAL DIMENSION - AN IMPORTANT ADDITION TO THE ASSESSMENT OF QUALITY-OF-LIFE - VALIDATION OF A QUESTIONNAIRE (SELT-M) IN PATIENTS WITH ADVANCED CANCER
    Annals of oncology
    
    B. Vanwegberg et al., "THE COGNITIVE-SPIRITUAL DIMENSION - AN IMPORTANT ADDITION TO THE ASSESSMENT OF QUALITY-OF-LIFE - VALIDATION OF A QUESTIONNAIRE (SELT-M) IN PATIENTS WITH ADVANCED CANCER", Annals of oncology, 9(10), 1998, pp. 1091-1096
18. BERNHARD J; GELBER RD; HURNY C
    WORKSHOP ON MISSING DATA IN QUALITY-OF-LIFE RESEARCH IN CANCER CLINICAL-TRIALS - PRACTICAL AND METHODOLOGICAL ISSUES - PREFACE
    Statistics in medicine
    
    J. Bernhard et al., "WORKSHOP ON MISSING DATA IN QUALITY-OF-LIFE RESEARCH IN CANCER CLINICAL-TRIALS - PRACTICAL AND METHODOLOGICAL ISSUES - PREFACE", Statistics in medicine, 17(5-7), 1998, pp. 511-512
19. BERNHARD J; CELLA DF; COATES AS; FALLOWFIELD L; GANZ PA; MOINPOUR CM; MOSCONI P; OSOBA D; SIMES J; HURNY C
    MISSING QUALITY-OF-LIFE DATA IN CANCER CLINICAL-TRIALS - SERIOUS PROBLEMS AND CHALLENGES
    Statistics in medicine
    
    J. Bernhard et al., "MISSING QUALITY-OF-LIFE DATA IN CANCER CLINICAL-TRIALS - SERIOUS PROBLEMS AND CHALLENGES", Statistics in medicine, 17(5-7), 1998, pp. 517-532
20. BERNHARD J; PETERSON HF; COATES AS; GUSSET H; ISLEY M; HINKLE R; GELBER RD; CASTIGLIONEGERTSCH M; HURNY C
    QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA
    Statistics in medicine
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA", Statistics in medicine, 17(5-7), 1998, pp. 587-601
21. BERNHARD J; GUSSET H; HURNY C
    PRACTICAL ISSUES IN QUALITY-OF-LIFE ASSESSMENT IN MULTICENTER TRIALS CONDUCTED BY THE SWISS-GROUP-FOR-CLINICAL-CANCER-RESEARCH
    Statistics in medicine
    
    J. Bernhard et al., "PRACTICAL ISSUES IN QUALITY-OF-LIFE ASSESSMENT IN MULTICENTER TRIALS CONDUCTED BY THE SWISS-GROUP-FOR-CLINICAL-CANCER-RESEARCH", Statistics in medicine, 17(5-7), 1998, pp. 633-639
22. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GALLIGIONI E; MARINI G; THURLIMANN B; FORBES JF; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
    FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS
    British Journal of Cancer
    
    J. Bernhard et al., "FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS", British Journal of Cancer, 78(5), 1998, pp. 686-693
23. HURNY C; VANWEGBERG B; BACCHI M; BERNHARD J; THURLIMANN B; REAL O; PEREY L; BONNEFOI H; COATES A
    SUBJECTIVE HEALTH ESTIMATIONS (SHE) IN PATIENTS WITH ADVANCED BREAST-CANCER - AN ADAPTED UTILITY CONCEPT FOR CLINICAL-TRIALS
    British Journal of Cancer
    
    C. Hurny et al., "SUBJECTIVE HEALTH ESTIMATIONS (SHE) IN PATIENTS WITH ADVANCED BREAST-CANCER - AN ADAPTED UTILITY CONCEPT FOR CLINICAL-TRIALS", British Journal of Cancer, 77(6), 1998, pp. 985-991
24. BERNHARD J; HURNY C; PETERSON HF; GELBER RD; CASTIGLIONEGERTSCH M; COATES AS
    QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER
    Quality of life research
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER", Quality of life research, 6(7-8), 1997, pp. 36-36
25. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
    QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH
    Annals of oncology
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH", Annals of oncology, 8(9), 1997, pp. 825-835
26. CASTIGLIONEGERTSCH M; GOLDHIRSCH A; GUSTERSON B; BETTELHEIM R; REED R; GUSSET H; GEISER K; HURNY C; BERNHARD J; HANGARTNER A; MAIBACH R; PEDOWSKI R; GELBER R; PRICE K; PETERSON H; ZELEN M; ISLEY M; HINKLE R; KAY RG; HOLDAWAY IM; HARVEY VJ; JAGUSCH MF; NEAVE L; MASON BM; EVANS B; BENJAMIN CS; CARTER JF; GILLMAN JC; MACK D; BENSONCOOPER D; MONFARDINI S; GALLIGIONI E; CRIVELLARI D; BUONADONNA A; MASSARUT S; ROSSI C; CANDIANI E; CARBONE A; VOLPE R; TROVO MG; RONCADIN M; SANTINI GF; VILLALTA D; CORAN F; MORASSUT S; MARINI G; SIMONCINI E; MARPICATI P; ZANIBONI A; SARTORI U; BARNI A; CERUTTI L; ALGHISI A; RAFFAGLIO E; GARATTINI MP; ALBERTINI A; GRIGOLATO F; MORASSI L; BERGONZINI R; LAURIOLA C; GUDGEON A; DENT DM; TILTMAN A; HACKING A; DOWDLE E; STEYNOR P; TOOP J; SCHNURCH HG; MOSNY D; BENDER HG; BOJAR H; VERONESI A; FOLADORE S; PAMICH G; BIANCHI G; TORRETTA A; RUDENSTAM CM; WALLGREN A; PERSSON S; MATTSSON J; CAHLIN E; HAFSTROM LO; HOLMBERG S; HULTBORN R; COLLDAHLJADERSTROM G; GUSTAVSSON B; CARLSSON G; IVARSSON L; THOREN O; RUUSVIK O; NICKLASSON LG; DAHLIN S; KARLSSON G; LINDBERG B; SUNDBACK A; BERGEGARDH S; SALANDER H; ANDERSSON C; HESSMAN Y; NELZEN O; HEIDEMAN M; RAMHULT T; SVENSSON JH; LIDBERG P; BJORK S; LINDTNER J; ERZEN D; CERAR O; STABUC B; GOLOUH R; LAMOVEC J; SEBEK S; KRAMBERGER M; VRHOVEC I; CORTESFUNES H; MARTINEZTELLO F; MENDIOLA C; CRUZVIGO F; LARRODERA ML; SIERRA A; MIRANDA P; ALONSO S; COLLINS J; SNYDER R; GREGORY P; BURAS WI; GREEN M; GALE T; HENDERSON M; HART S; NEIL S; KITCHEN P; LOVELL R; MCLENNAN R; REED R; RUSSELL I; SCHWARZ M; BASSER R; ROBERTSON A; GILL P; CARTER ML; MALYCHA P; YEOH E; WARD G; LEONG ASY; LOMMAXSMITH J; HOOSFALL D; DANGELO R; BYRNE M; VANHAZEL G; DEWAR J; BUCK M; SHEINER HJ; INGRAM D; STERRETT G; HAHNEL R; FORBES JF; STEWARD J; DARBAR SW; BISHOP JM; SIMMS B; ZIOGAS V; TATTERSALL MHN; COATES A; NIESCHE F; WEST R; RENWICK S; DONOVAN J; DUVAL P; SIMES RJ; NG A; GLENN D; NORTH RA; BEITH J; OCONNOR RG; RICE M; STEVENS G; FEY M; BARTH A; DREHER E; ISENSCHMID M; SCHNEIDER H; BUSER K; LUDIN J; LUTHI JM; ALTERMATT HJ; LAISSUE JA; MARKWALDER R; BURGI H; SENN HJ; THURLIMANN B; JUNGI WF; MORANT R; OEHLSCHLEGEL C; HARDMEIER T; LUSCHER K; RIES G; TOPFER M; LORENZ U; BENZ D; SCHILTKNECHT O; SPATI B; SCHMID L; CAVALLI F; SESSA C; BRONZ L; MARTINELLI G; MULLER W; LUSCIETI P; PASSEGA E; PEDRINIS E; REY P; MARTINOLI S; SPINELLI A; GALFETTI MA; LOMBARDI A; PEDRAZZINI A; LOSA G; VARINI M; GINIER M; HERRMANN R; HARDER JF; LAFFER U; ALMENDRAL AC; EPPENBERGER U; TORHORST J; SIEGENTHALER P; PIGUET D; BARRELET V; BAUMANN RP; JOSS R; SAUTER C; METZGER U; ENGELER V; HALLER U; KOCHLI O; LEYVRAZ S; PEREY L; ANANI P; GOMEZ F; MIRIMANOFF RO; CHAPUIS G; DEGRANDI P; REYMOND P; ALBERTO P; SCHAFER P; KRAUER F; FORNI M; AAPRO M; EGELI R; MEGEVAND R; JACOTDESCOMBES E; SCHINDLER A; NOSEDA G; WEBER W; LEHMANN W
    EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS
    Journal of clinical oncology
    
    M. Castiglionegertsch et al., "EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS", Journal of clinical oncology, 15(4), 1997, pp. 1385-1394
27. HURNY C
    IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER (VOL 347, PG 1279, 1996)
    Lancet
    
    C. Hurny, "IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER (VOL 347, PG 1279, 1996)", Lancet, 350(9073), 1997, pp. 298-298
28. ADLER RH; ZAMBONI P; HOFER T; HEMMELER W; HURNY C; MINDER C; RADVILA A; ZLOT SI
    HOW NOT TO MISS A SOMATIC NEEDLE IN THE HAYSTACK OF CHRONIC PAIN
    Journal of psychosomatic research
    
    R.H. Adler et al., "HOW NOT TO MISS A SOMATIC NEEDLE IN THE HAYSTACK OF CHRONIC PAIN", Journal of psychosomatic research, 42(5), 1997, pp. 499-505
29. HURNY C; BERNHARD J; COATES AS; CASTIGLIONEGERTSCH M; PETERSON HF; GELBER RD; FORBES JF; RUDENSTAM CM; SIMONCINI E; CRIVELLARI D; GOLDHIRSCH A; SENN HJ
    IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER
    Lancet
    
    C. Hurny et al., "IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER", Lancet, 347(9011), 1996, pp. 1279-1284
30. BERNHARD J; HURNY C; BACCHI M; JOSS RA; CAVALLI F; SENN HJ; LEYVRAZ S; STAHEL R; LUDWIG C; ALBERTO P
    INITIAL PROGNOSTIC FACTORS IN SMALL-CELL LUNG-CANCER PATIENTS PREDICTING QUALITY-OF-LIFE DURING CHEMOTHERAPY
    British Journal of Cancer
    
    J. Bernhard et al., "INITIAL PROGNOSTIC FACTORS IN SMALL-CELL LUNG-CANCER PATIENTS PREDICTING QUALITY-OF-LIFE DURING CHEMOTHERAPY", British Journal of Cancer, 74(10), 1996, pp. 1660-1667
31. BERNHARD J; GUSSET H; HURNY C
    QUALITY-OF-LIFE ASSESSMENT IN CANCER CLINICAL-TRIALS - AN INTERVENTION BY ITSELF
    Supportive care in cancer
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN CANCER CLINICAL-TRIALS - AN INTERVENTION BY ITSELF", Supportive care in cancer, 3(1), 1995, pp. 66-71
32. JOSS RA; BACCHI M; HURNY C; BERNHARD J; CERNY T; MARTINELLI G; LEYVRAZ S; SENN HJ; STAHEL R; SIEGENTHALER P; LUDWIG C; ALBERTO P
    EARLY VERSUS LATE ALTERNATING CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
    Annals of oncology
    
    R.A. Joss et al., "EARLY VERSUS LATE ALTERNATING CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER", Annals of oncology, 6(2), 1995, pp. 157-166
33. JOSS RA; ALBERTO P; HURNY C; BACCHI M; LEYVRAZ S; THURLIMANN B; CERNY T; MARTINELLI G; STAHEL R; LUDWIG C
    QUALITY VERSUS QUANTITY OF LIFE IN THE TREATMENT OF PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III COMPARISON OF WEEKLY CARBOPLATIN AND TENIPOSIDE VERSUS CISPLATIN, ADRIAMYCIN, ETOPOSIDE ALTERNATING WITH CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND LOMUSTINE
    Annals of oncology
    
    R.A. Joss et al., "QUALITY VERSUS QUANTITY OF LIFE IN THE TREATMENT OF PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III COMPARISON OF WEEKLY CARBOPLATIN AND TENIPOSIDE VERSUS CISPLATIN, ADRIAMYCIN, ETOPOSIDE ALTERNATING WITH CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND LOMUSTINE", Annals of oncology, 6(1), 1995, pp. 41-48
34. HURNY C; BERNHARD J; COATES A; PETERSON HF; GELBER RD
    THE QUALITY OF QUALITY-OF-LIFE MEASUREMENTS
    JAMA, the journal of the American Medical Association
    
    C. Hurny et al., "THE QUALITY OF QUALITY-OF-LIFE MEASUREMENTS", JAMA, the journal of the American Medical Association, 273(11), 1995, pp. 843-843
35. GOLDHIRSCH A; GELBER RD; CASTIGLIONE M; PRICE KN; RUDENSTAM CM; LINDTNER J; COLLINS J; SENN HJ; CAVALLI F; GALLIGIONI E; FEY M; GUDGEON A; CORTESFUNES H; TATTERSALL M; MARINI G; BYRNE M; SNYDER R; FORBES JF; KAY R; HURNY C; THURLIMANN B; REED R; GUSTERSON B; TORHORST J; SAVESODERBERGH J; COATES A
    THE BEST AVAILABLE ADJUVANT TREATMENTS ARE WITHIN THE FRAMEWORK OF CLINICAL-TRIALS - THE INTERNATIONAL BREAST-CANCER STUDY-GROUP
    Israel journal of medical sciences
    
    A. Goldhirsch et al., "THE BEST AVAILABLE ADJUVANT TREATMENTS ARE WITHIN THE FRAMEWORK OF CLINICAL-TRIALS - THE INTERNATIONAL BREAST-CANCER STUDY-GROUP", Israel journal of medical sciences, 31(2-3), 1995, pp. 144-154
36. HURNY C
    PALLIATIVE CARE IN HIGH-TECH MEDICINE - DEFINING THE POINT-OF-NO-RETURN
    Supportive care in cancer
    
    C. Hurny, "PALLIATIVE CARE IN HIGH-TECH MEDICINE - DEFINING THE POINT-OF-NO-RETURN", Supportive care in cancer, 2(1), 1994, pp. 3-4
37. HURNY C; BERNHARD J; COATES A; CASTIGLIONE M; PETERSON HF; GELBER RD; RUDENSTAM CM; GOLDHIRSCH A; SENN HJ
    TIMING OF BASE-LINE QUALITY-OF-LIFE ASSESSMENT IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL - ITS EFFECT ON PATIENT SELF-ESTIMATION
    Annals of oncology
    
    C. Hurny et al., "TIMING OF BASE-LINE QUALITY-OF-LIFE ASSESSMENT IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL - ITS EFFECT ON PATIENT SELF-ESTIMATION", Annals of oncology, 5(1), 1994, pp. 65-74
38. HURNY C; BERNHARD J
    LESSONS LEARNED FROM MEASURING HEALTH-RELATED QUALITY-OF-LIFE IN ONCOLOGY
    Journal of clinical oncology
    
    C. Hurny e J. Bernhard, "LESSONS LEARNED FROM MEASURING HEALTH-RELATED QUALITY-OF-LIFE IN ONCOLOGY", Journal of clinical oncology, 12(9), 1994, pp. 1994-1994
39. SCHWARZ R; BERNHARD J; FLECHTNER H; HURNY C; KUCHLER T
    GUIDELINES FOR THE ASSESSMENT OF QUALITY-OF-LIFE IN ONCOLOGY IMPLEMENTING ADEQUATE METHODS AND THEIR CONTENT
    Journal of cancer research and clinical oncology
    
    R. Schwarz et al., "GUIDELINES FOR THE ASSESSMENT OF QUALITY-OF-LIFE IN ONCOLOGY IMPLEMENTING ADEQUATE METHODS AND THEIR CONTENT", Journal of cancer research and clinical oncology, 120(11), 1994, pp. 691-692
40. HURNY C; HEUSSER P; BERNHARD J; CASTIGLIONE M; CERNY T
    DO NONCONVENTIONAL, COMPLEMENTARY MEDICIN E THERAPIES IMPROVE THE LIFE QUALITY OF CANCER-PATIENTS
    Schweizerische medizinische Wochenschrift
    
    C. Hurny et al., "DO NONCONVENTIONAL, COMPLEMENTARY MEDICIN E THERAPIES IMPROVE THE LIFE QUALITY OF CANCER-PATIENTS", Schweizerische medizinische Wochenschrift, 124(30), 1994, pp. 55-63
41. GOLDHIRSCH A; GELBER RD; CASTIGLIONE M; PRICE KN; RUDENSTAM CM; LINDTNER J; COLLINS J; SENN HJ; BRUNNER KW; GALLIGIONI E; CAVALLI F; GUDGEON A; CORTESFUNES H; TATTERSALL M; MARINI G; BYRNE M; SNYDER R; FORBES JF; HURNY C; COATES A
    PRESENT AND FUTURE PROJECTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP
    Cancer
    
    A. Goldhirsch et al., "PRESENT AND FUTURE PROJECTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP", Cancer, 74(3), 1994, pp. 1139-1149
42. HURNY C; BERNHARD J; JOSS R; SCHATZMANN E; CAVALLI F; BRUNNER K; ALBERTO P; SENN HJ; METZGER U
    FATIGUE AND MALAISE AS A QUALITY-OF-LIFE INDICATOR IN SMALL-CELL LUNG-CANCER PATIENTS
    Supportive care in cancer
    
    C. Hurny et al., "FATIGUE AND MALAISE AS A QUALITY-OF-LIFE INDICATOR IN SMALL-CELL LUNG-CANCER PATIENTS", Supportive care in cancer, 1(6), 1993, pp. 316-320
43. HURNY C; BERNHARD J; BACCHI M; VANWEGBERG B; TOMAMICHEL M; SPEK U; COATES A; CASTIGLIONE M; GOLDHIRSCH A; SENN HJ
    THE PERCEIVED ADJUSTMENT TO CHRONIC ILLNESS SCALE (PACIS) - A GLOBAL INDICATOR OF COPING FOR OPERABLE BREAST-CANCER PATIENTS IN CLINICAL-TRIALS
    Supportive care in cancer
    
    C. Hurny et al., "THE PERCEIVED ADJUSTMENT TO CHRONIC ILLNESS SCALE (PACIS) - A GLOBAL INDICATOR OF COPING FOR OPERABLE BREAST-CANCER PATIENTS IN CLINICAL-TRIALS", Supportive care in cancer, 1(4), 1993, pp. 200-208
44. HURNY C
    ASSESSING QUALITY-OF-LIFE IN CLINICAL-TRIALS - REPLY
    Annals of oncology
    
    C. Hurny, "ASSESSING QUALITY-OF-LIFE IN CLINICAL-TRIALS - REPLY", Annals of oncology, 4(6), 1993, pp. 520-520